Abaloparatide

Label

ClassPTHrP analog

Typical routes in papersDaily SC on label

Half-life contextShort

EvidenceFDA-approved osteoporosis anabolic

What it is

Abaloparatide is a PTHrP analog (Tymlos) — another daily bone-building shot in the same conversation as teriparatide.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

Label job: raise bone density and cut fracture risk in selected osteoporosis patients.
Same “pulse anabolic, don’t improvise” rule as Forteo.
Not a sports-recovery peptide.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Selective PTH1R signaling biased toward anabolic bone formation vs continuous catabolic tone.

Possible side effects / caveats

Hypercalcemia, palpitations, injection reactions, duration limits.

Protocol ranges

Source tier	Amount	Frequency / duration	Notes
Label	80 mcg	Daily SC	Confirm current Tymlos insert

Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.